| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | diacylglycerol binding | 2.27e-06 | 16 | 33 | 3 | GO:0019992 | |
| GeneOntologyMolecularFunction | phorbol ester receptor activity | 2.65e-06 | 2 | 33 | 2 | GO:0001565 | |
| GeneOntologyMolecularFunction | non-kinase phorbol ester receptor activity | 2.65e-06 | 2 | 33 | 2 | GO:0001566 | |
| GeneOntologyMolecularFunction | syntaxin-1 binding | 8.13e-06 | 24 | 33 | 3 | GO:0017075 | |
| GeneOntologyMolecularFunction | syntaxin binding | 3.97e-04 | 87 | 33 | 3 | GO:0019905 | |
| GeneOntologyMolecularFunction | calmodulin binding | 5.40e-04 | 230 | 33 | 4 | GO:0005516 | |
| GeneOntologyMolecularFunction | SNARE binding | 1.45e-03 | 136 | 33 | 3 | GO:0000149 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase inhibitor activity | 2.29e-03 | 43 | 33 | 2 | GO:0004869 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 3.22e-03 | 180 | 33 | 3 | GO:0004866 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 3.59e-03 | 187 | 33 | 3 | GO:0030414 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 4.39e-03 | 201 | 33 | 3 | GO:0061135 | |
| GeneOntologyBiologicalProcess | dense core granule priming | 1.64e-08 | 4 | 34 | 3 | GO:0061789 | |
| GeneOntologyBiologicalProcess | presynaptic dense core vesicle exocytosis | 4.87e-07 | 10 | 34 | 3 | GO:0099525 | |
| GeneOntologyBiologicalProcess | neuronal dense core vesicle exocytosis | 8.91e-07 | 12 | 34 | 3 | GO:0099011 | |
| GeneOntologyBiologicalProcess | dense core granule exocytosis | 1.84e-06 | 15 | 34 | 3 | GO:1990504 | |
| GeneOntologyBiologicalProcess | dense core granule docking | 2.64e-06 | 2 | 34 | 2 | GO:0061790 | |
| GeneOntologyBiologicalProcess | synaptic vesicle docking | 2.74e-06 | 17 | 34 | 3 | GO:0016081 | |
| GeneOntologyBiologicalProcess | calcium ion-regulated exocytosis of neurotransmitter | 9.18e-06 | 25 | 34 | 3 | GO:0048791 | |
| GeneOntologyBiologicalProcess | dense core granule localization | 1.30e-05 | 28 | 34 | 3 | GO:0032253 | |
| GeneOntologyBiologicalProcess | synaptic vesicle priming | 1.78e-05 | 31 | 34 | 3 | GO:0016082 | |
| GeneOntologyBiologicalProcess | secretory granule localization | 2.36e-05 | 34 | 34 | 3 | GO:0032252 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic plasticity | 3.94e-05 | 6 | 34 | 2 | GO:0031914 | |
| GeneOntologyBiologicalProcess | vesicle docking involved in exocytosis | 5.17e-05 | 44 | 34 | 3 | GO:0006904 | |
| GeneOntologyBiologicalProcess | vesicle docking | 1.67e-04 | 65 | 34 | 3 | GO:0048278 | |
| GeneOntologyBiologicalProcess | neuromuscular junction development | 1.91e-04 | 68 | 34 | 3 | GO:0007528 | |
| GeneOntologyBiologicalProcess | response to redox state | 2.37e-04 | 14 | 34 | 2 | GO:0051775 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle priming | 2.37e-04 | 14 | 34 | 2 | GO:0010807 | |
| GeneOntologyBiologicalProcess | establishment of organelle localization | 2.40e-04 | 546 | 34 | 6 | GO:0051656 | |
| GeneOntologyBiologicalProcess | calcium-ion regulated exocytosis | 3.32e-04 | 82 | 34 | 3 | GO:0017156 | |
| GeneOntologyBiologicalProcess | regulation of neuronal synaptic plasticity | 3.44e-04 | 83 | 34 | 3 | GO:0048168 | |
| GeneOntologyBiologicalProcess | organelle localization by membrane tethering | 3.69e-04 | 85 | 34 | 3 | GO:0140056 | |
| GeneOntologyBiologicalProcess | spontaneous synaptic transmission | 3.97e-04 | 18 | 34 | 2 | GO:0098814 | |
| GeneOntologyBiologicalProcess | membrane docking | 4.50e-04 | 91 | 34 | 3 | GO:0022406 | |
| GeneOntologyBiologicalProcess | regulation of short-term neuronal synaptic plasticity | 5.97e-04 | 22 | 34 | 2 | GO:0048172 | |
| GeneOntologyBiologicalProcess | developmental growth | 6.05e-04 | 911 | 34 | 7 | GO:0048589 | |
| GeneOntologyBiologicalProcess | exocytic process | 7.23e-04 | 107 | 34 | 3 | GO:0140029 | |
| GeneOntologyBiologicalProcess | growth | 7.24e-04 | 1235 | 34 | 8 | GO:0040007 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron migration | 7.73e-04 | 25 | 34 | 2 | GO:2001224 | |
| GeneOntologyBiologicalProcess | neurotransmitter transport | 8.38e-04 | 259 | 34 | 4 | GO:0006836 | |
| GeneOntologyBiologicalProcess | synaptic vesicle cycle | 8.99e-04 | 264 | 34 | 4 | GO:0099504 | |
| GeneOntologyBiologicalProcess | organelle localization | 9.13e-04 | 703 | 34 | 6 | GO:0051640 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | 9.38e-04 | 981 | 34 | 7 | GO:0019725 | |
| GeneOntologyCellularComponent | neuromuscular junction | 8.50e-07 | 112 | 33 | 5 | GO:0031594 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 6.21e-06 | 23 | 33 | 3 | GO:0098831 | |
| GeneOntologyCellularComponent | calyx of Held | 2.47e-05 | 36 | 33 | 3 | GO:0044305 | |
| GeneOntologyCellularComponent | cell cortex region | 4.86e-05 | 45 | 33 | 3 | GO:0099738 | |
| GeneOntologyCellularComponent | presynaptic active zone | 6.97e-05 | 141 | 33 | 4 | GO:0048786 | |
| GeneOntologyCellularComponent | terminal bouton | 4.63e-04 | 96 | 33 | 3 | GO:0043195 | |
| GeneOntologyCellularComponent | secretory vesicle | 5.67e-04 | 1246 | 33 | 8 | GO:0099503 | |
| GeneOntologyCellularComponent | synaptic vesicle | 1.23e-03 | 300 | 33 | 4 | GO:0008021 | |
| GeneOntologyCellularComponent | exocytic vesicle | 1.55e-03 | 320 | 33 | 4 | GO:0070382 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 2.39e-03 | 46 | 33 | 2 | GO:0005790 | |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 2.79e-03 | 179 | 33 | 3 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 2.79e-03 | 179 | 33 | 3 | GO:0030672 | |
| GeneOntologyCellularComponent | axon terminus | 4.37e-03 | 210 | 33 | 3 | GO:0043679 | |
| GeneOntologyCellularComponent | distal axon | 4.69e-03 | 435 | 33 | 4 | GO:0150034 | |
| GeneOntologyCellularComponent | platelet alpha granule lumen | 5.01e-03 | 67 | 33 | 2 | GO:0031093 | |
| GeneOntologyCellularComponent | neuron projection terminus | 5.83e-03 | 233 | 33 | 3 | GO:0044306 | |
| GeneOntologyCellularComponent | dendritic shaft | 6.08e-03 | 74 | 33 | 2 | GO:0043198 | |
| Domain | Unc-13 | 4.57e-09 | 3 | 32 | 3 | IPR027080 | |
| Domain | Munc13_dom-2 | 4.56e-08 | 5 | 32 | 3 | IPR014772 | |
| Domain | Membr_traf_MHD | 4.56e-08 | 5 | 32 | 3 | PF10540 | |
| Domain | DUF1041 | 4.56e-08 | 5 | 32 | 3 | SM01145 | |
| Domain | MHD2 | 4.56e-08 | 5 | 32 | 3 | PS51259 | |
| Domain | Munc13_subgr_dom-2 | 4.56e-08 | 5 | 32 | 3 | IPR019558 | |
| Domain | DUF1041 | 1.59e-07 | 7 | 32 | 3 | PF06292 | |
| Domain | Munc13_1 | 1.59e-07 | 7 | 32 | 3 | IPR014770 | |
| Domain | CAPS_dom | 1.59e-07 | 7 | 32 | 3 | IPR010439 | |
| Domain | MHD1 | 1.59e-07 | 7 | 32 | 3 | PS51258 | |
| Domain | C1_1 | 2.63e-06 | 57 | 32 | 4 | PF00130 | |
| Domain | ZF_DAG_PE_1 | 4.19e-06 | 64 | 32 | 4 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 4.19e-06 | 64 | 32 | 4 | PS50081 | |
| Domain | C1 | 4.46e-06 | 65 | 32 | 4 | SM00109 | |
| Domain | PE/DAG-bd | 4.75e-06 | 66 | 32 | 4 | IPR002219 | |
| Domain | GLUTAREDOXIN_1 | 4.25e-05 | 6 | 32 | 2 | PS00195 | |
| Domain | TLV/ENV_coat_polyprotein | 7.91e-05 | 8 | 32 | 2 | IPR018154 | |
| Domain | GLUTAREDOXIN_2 | 1.02e-04 | 9 | 32 | 2 | PS51354 | |
| Domain | Glutaredoxin | 1.02e-04 | 9 | 32 | 2 | PF00462 | |
| Domain | Glutaredoxin | 1.27e-04 | 10 | 32 | 2 | IPR002109 | |
| Domain | TIL | 1.86e-04 | 12 | 32 | 2 | PF01826 | |
| Domain | C8 | 1.86e-04 | 12 | 32 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 2.19e-04 | 13 | 32 | 2 | IPR014853 | |
| Domain | C8 | 2.19e-04 | 13 | 32 | 2 | SM00832 | |
| Domain | TIL_dom | 2.55e-04 | 14 | 32 | 2 | IPR002919 | |
| Domain | VWFD | 3.36e-04 | 16 | 32 | 2 | PS51233 | |
| Domain | VWD | 3.36e-04 | 16 | 32 | 2 | SM00216 | |
| Domain | VWF_type-D | 3.36e-04 | 16 | 32 | 2 | IPR001846 | |
| Domain | VWD | 3.36e-04 | 16 | 32 | 2 | PF00094 | |
| Domain | CTCK_1 | 4.28e-04 | 18 | 32 | 2 | PS01185 | |
| Domain | VWC_out | 4.78e-04 | 19 | 32 | 2 | SM00215 | |
| Domain | CT | 6.43e-04 | 22 | 32 | 2 | SM00041 | |
| Domain | Cys_knot_C | 8.32e-04 | 25 | 32 | 2 | IPR006207 | |
| Domain | CTCK_2 | 8.32e-04 | 25 | 32 | 2 | PS01225 | |
| Domain | C2 | 1.44e-03 | 131 | 32 | 3 | PF00168 | |
| Domain | C2 | 1.64e-03 | 137 | 32 | 3 | SM00239 | |
| Domain | VWFC_1 | 1.73e-03 | 36 | 32 | 2 | PS01208 | |
| Domain | C2 | 1.82e-03 | 142 | 32 | 3 | PS50004 | |
| Domain | VWC | 1.92e-03 | 38 | 32 | 2 | SM00214 | |
| Domain | VWFC_2 | 1.92e-03 | 38 | 32 | 2 | PS50184 | |
| Domain | - | 2.04e-03 | 148 | 32 | 3 | 2.60.40.150 | |
| Domain | VWF_dom | 2.35e-03 | 42 | 32 | 2 | IPR001007 | |
| Domain | C2_dom | 2.73e-03 | 164 | 32 | 3 | IPR000008 | |
| Domain | VWA | 4.13e-03 | 56 | 32 | 2 | PF00092 | |
| Domain | - | 7.11e-03 | 74 | 32 | 2 | 3.40.50.410 | |
| Domain | VWFA | 8.67e-03 | 82 | 32 | 2 | PS50234 | |
| Domain | VWA | 9.08e-03 | 84 | 32 | 2 | SM00327 | |
| Pathway | WP_SYNAPTIC_VESICLE_PATHWAY | 8.56e-05 | 51 | 24 | 3 | M39457 | |
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 23658173 | ||
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 33105896 | ||
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 22966208 | ||
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 15988013 | ||
| Pubmed | Munc13-1-mediated vesicle priming contributes to secretory amyloid precursor protein processing. | 3.41e-09 | 4 | 34 | 3 | 15123597 | |
| Pubmed | An active vesicle priming machinery suppresses axon regeneration upon adult CNS injury. | 8.52e-09 | 5 | 34 | 3 | 34706221 | |
| Pubmed | Identification of a Munc13-sensitive step in chromaffin cell large dense-core vesicle exocytosis. | 8.52e-09 | 5 | 34 | 3 | 26575293 | |
| Pubmed | Munc13 supports fusogenicity of non-docked vesicles at synapses with disrupted active zones. | 2.98e-08 | 7 | 34 | 3 | 36398873 | |
| Pubmed | Unconventional molecular regulation of synaptic vesicle replenishment in cochlear inner hair cells. | 4.76e-08 | 8 | 34 | 3 | 25609709 | |
| Pubmed | Molecular and functional architecture of striatal dopamine release sites. | 1.40e-07 | 11 | 34 | 3 | 34767769 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 12070347 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 12871971 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 17561838 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 23070049 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 32966798 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 9407109 | ||
| Pubmed | Heterodimerization of Munc13 C2A domain with RIM regulates synaptic vesicle docking and priming. | 9.28e-07 | 2 | 34 | 2 | 28489077 | |
| Pubmed | Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles. | 9.28e-07 | 2 | 34 | 2 | 10440375 | |
| Pubmed | Inhibition of exocytosis or endocytosis blocks activity-dependent redistribution of synapsin. | 9.28e-07 | 2 | 34 | 2 | 22066784 | |
| Pubmed | Ultrastructural Correlates of Presynaptic Functional Heterogeneity in Hippocampal Synapses. | 9.28e-07 | 2 | 34 | 2 | 32187536 | |
| Pubmed | Molecular Mechanisms of Synaptic Vesicle Priming by Munc13 and Munc18. | 9.28e-07 | 2 | 34 | 2 | 28772123 | |
| Pubmed | Munc13-1 C1 domain activation lowers the energy barrier for synaptic vesicle fusion. | 9.28e-07 | 2 | 34 | 2 | 17267576 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 22814762 | ||
| Pubmed | Formation and Maintenance of Functional Spines in the Absence of Presynaptic Glutamate Release. | 9.28e-07 | 2 | 34 | 2 | 28426965 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 35613050 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 23770256 | ||
| Pubmed | Membrane bridging by Munc13-1 is crucial for neurotransmitter release. | 9.28e-07 | 2 | 34 | 2 | 30816091 | |
| Pubmed | Munc13-independent vesicle priming at mouse photoreceptor ribbon synapses. | 9.28e-07 | 2 | 34 | 2 | 22674279 | |
| Pubmed | A common molecular basis for membrane docking and functional priming of synaptic vesicles. | 9.28e-07 | 2 | 34 | 2 | 19558619 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 18701688 | ||
| Pubmed | Calcium-Independent Exo-endocytosis Coupling at Small Central Synapses. | 9.28e-07 | 2 | 34 | 2 | 31851910 | |
| Pubmed | Differential control of vesicle priming and short-term plasticity by Munc13 isoforms. | 9.28e-07 | 2 | 34 | 2 | 11832228 | |
| Pubmed | Munc13 controls the location and efficiency of dense-core vesicle release in neurons. | 9.28e-07 | 2 | 34 | 2 | 23229896 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 11792326 | ||
| Pubmed | Redundant functions of RIM1alpha and RIM2alpha in Ca(2+)-triggered neurotransmitter release. | 2.19e-06 | 26 | 34 | 3 | 17124501 | |
| Pubmed | Munc13- and SNAP25-dependent molecular bridges play a key role in synaptic vesicle priming. | 2.78e-06 | 3 | 34 | 2 | 37343100 | |
| Pubmed | The role of syncytins in human reproduction and reproductive organ cancers. | 2.78e-06 | 3 | 34 | 2 | 27486264 | |
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 17639022 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 28476886 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 26992684 | ||
| Pubmed | 3.77e-06 | 31 | 34 | 3 | 15217342 | ||
| Pubmed | Transient, phorbol ester-induced DOC2-Munc13 interactions in vivo. | 5.56e-06 | 4 | 34 | 2 | 10488064 | |
| Pubmed | Fbxo45, a novel ubiquitin ligase, regulates synaptic activity. | 5.56e-06 | 4 | 34 | 2 | 19996097 | |
| Pubmed | ELKS1 localizes the synaptic vesicle priming protein bMunc13-2 to a specific subset of active zones. | 5.56e-06 | 4 | 34 | 2 | 28264913 | |
| Pubmed | A SPRY1 domain cardiac ryanodine receptor variant associated with short-coupled torsade de pointes. | 5.56e-06 | 4 | 34 | 2 | 33664309 | |
| Pubmed | 9.26e-06 | 5 | 34 | 2 | 32755572 | ||
| Pubmed | 9.26e-06 | 5 | 34 | 2 | 22248876 | ||
| Pubmed | Disentangling the Roles of RIM and Munc13 in Synaptic Vesicle Localization and Neurotransmission. | 9.26e-06 | 5 | 34 | 2 | 33139401 | |
| Pubmed | Munc13-1 and Munc18-1 together prevent NSF-dependent de-priming of synaptic vesicles. | 1.39e-05 | 6 | 34 | 2 | 28635948 | |
| Pubmed | 1.78e-05 | 335 | 34 | 5 | 15741177 | ||
| Pubmed | 1.94e-05 | 7 | 34 | 2 | 15893389 | ||
| Pubmed | 2.59e-05 | 8 | 34 | 2 | 33504453 | ||
| Pubmed | 4.15e-05 | 10 | 34 | 2 | 12970426 | ||
| Pubmed | SNARE protein recycling by αSNAP and βSNAP supports synaptic vesicle priming. | 4.15e-05 | 10 | 34 | 2 | 21040848 | |
| Pubmed | The morphological and molecular nature of synaptic vesicle priming at presynaptic active zones. | 5.07e-05 | 11 | 34 | 2 | 25374362 | |
| Pubmed | 6.08e-05 | 12 | 34 | 2 | 14557543 | ||
| Pubmed | 1.41e-04 | 18 | 34 | 2 | 12684764 | ||
| Pubmed | Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1. | 1.93e-04 | 21 | 34 | 2 | 22959728 | |
| Pubmed | Lipid signatures reflect the function of the murine primary placentation†. | 2.12e-04 | 22 | 34 | 2 | 34850819 | |
| Interaction | GPR15 interactions | 7.32e-06 | 3 | 32 | 2 | int:GPR15 | |
| Interaction | DIRAS1 interactions | 1.43e-05 | 30 | 32 | 3 | int:DIRAS1 | |
| Interaction | UBXN10 interactions | 4.00e-05 | 42 | 32 | 3 | int:UBXN10 | |
| GeneFamily | UNC13 homologs | 1.19e-08 | 4 | 27 | 3 | 836 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 4.14e-07 | 200 | 34 | 5 | abf4ba5fcb54cdeada0da1a8b956a30aa47679e4 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.14e-07 | 200 | 34 | 5 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.42e-06 | 165 | 34 | 4 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.60e-06 | 166 | 34 | 4 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.97e-06 | 168 | 34 | 4 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| ToppCell | Nasal_Brush-Epithelial-Ionocytes|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.75e-06 | 172 | 34 | 4 | dd3a23dc78dc6939f41126f8d7bd23a2e4713647 | |
| ToppCell | Nasal_Brush-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.75e-06 | 172 | 34 | 4 | 04fabb40fa9357d8902f3b04adc15231626cd9f8 | |
| ToppCell | NS-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.02e-05 | 179 | 34 | 4 | 65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.07e-05 | 181 | 34 | 4 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.09e-05 | 182 | 34 | 4 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.12e-05 | 183 | 34 | 4 | ba43bca2b45be1008eebd3f033cecb061fb3a966 | |
| ToppCell | critical-Epithelial-Ionocyte|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.14e-05 | 184 | 34 | 4 | 58d36577eff814d46d72f031f3533d71549e3d6e | |
| ToppCell | critical-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.29e-05 | 190 | 34 | 4 | 05a2c3549b68f49081723bf35db14974274419d5 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.32e-05 | 191 | 34 | 4 | 8f4637e801554e2343b974fe7794f01dd2151418 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.32e-05 | 191 | 34 | 4 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.35e-05 | 192 | 34 | 4 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | distal-Hematologic-B_cell-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.38e-05 | 193 | 34 | 4 | 202dc5ec2437602c15658074728c5f5aeeab0466 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.40e-05 | 194 | 34 | 4 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 1.40e-05 | 194 | 34 | 4 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | distal-2-Hematologic-B_cell|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.46e-05 | 196 | 34 | 4 | 2587b5d83fb4f1c4a69894aa0f5f7cb3898faa09 | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.46e-05 | 196 | 34 | 4 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-05 | 197 | 34 | 4 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 1.55e-05 | 199 | 34 | 4 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.58e-05 | 200 | 34 | 4 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.58e-05 | 200 | 34 | 4 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.58e-05 | 200 | 34 | 4 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.18e-04 | 154 | 34 | 3 | e65e4636646164610f33f7bbac0d879a3ea55986 | |
| ToppCell | Ionocyte|World / shred by cell class for nasal brushing | 2.18e-04 | 154 | 34 | 3 | 6b78fb0c96fc7b5e901c39b3424f4aa8d0a6b9cf | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 158 | 34 | 3 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 158 | 34 | 3 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.44e-04 | 160 | 34 | 3 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.44e-04 | 160 | 34 | 3 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-04 | 161 | 34 | 3 | a006491c991e6a134be20ad75092a91f3b7c3c91 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-04 | 161 | 34 | 3 | 4f25eeabb841b0b9204cdd4e71d5e131e7868184 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-04 | 166 | 34 | 3 | 7c2eee0a4f45795a956acf936b85bdb35f1b1624 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-04 | 166 | 34 | 3 | 7286a37b2827f3747469ffd0d76cbe81116db7ee | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.81e-04 | 168 | 34 | 3 | 2163e6774eb7a3d010422e4d59be5e45b4158329 | |
| ToppCell | Ionocyte|World / Class top | 2.91e-04 | 170 | 34 | 3 | d2e592f2a679e6a8d32f2b752d9a3c493e50ced4 | |
| ToppCell | Ionocyte-iono-2|World / Class top | 3.06e-04 | 173 | 34 | 3 | e5ec28ccc5e048fd98de4c876e5c53b866b66228 | |
| ToppCell | Bronchial_Brush-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.06e-04 | 173 | 34 | 3 | e1de849dcd96063136bdac87e050ddbd55cabdcc | |
| ToppCell | Bronchial_Brush-Epithelial-Ionocytes|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.06e-04 | 173 | 34 | 3 | f2a8f4918c1fb68d98bc3f33cd624de0f0f11e06 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.27e-04 | 177 | 34 | 3 | 67cc3a6461db5e0678f96b18224aeb83ad34b0f4 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.27e-04 | 177 | 34 | 3 | 99500aed584f793aaf308f8afbf5d1c6a9b4ee55 | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|tumor_Lung / Location, Cell class and cell subclass | 3.27e-04 | 177 | 34 | 3 | f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.44e-04 | 180 | 34 | 3 | 8af8b4af2dc72223ac71fc027e0d4280c5dd81f8 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.44e-04 | 180 | 34 | 3 | 8ab16a0b9053bffc07b569a4f9e71749f56dde7e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.44e-04 | 180 | 34 | 3 | 16728b9a1c52097e3a460534be71a476ecc54f0f | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.44e-04 | 180 | 34 | 3 | 394cd465b88429b70eebb2957480dffcbc51cfe7 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-04 | 181 | 34 | 3 | d90faa6115b408c9fbca61fc90ff951e070754ba | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.55e-04 | 182 | 34 | 3 | d7cce5dd7046f06bf40f00c9dbfa610722b03333 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-04 | 182 | 34 | 3 | 11494a66d986297b837332ee9d382b71b9f22591 | |
| ToppCell | (4)_B_cells-(4)_B_mantle|(4)_B_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.61e-04 | 183 | 34 | 3 | 21b7fb6482eb1d5d31a4029e47e0992e8ddc8e2c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-04 | 183 | 34 | 3 | dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.61e-04 | 183 | 34 | 3 | 6c4a09c02e30e1f24dde39f8cb8c5b453826ee2e | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.61e-04 | 183 | 34 | 3 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-04 | 183 | 34 | 3 | 4759560e5b4f4e5a00e5f933e3451a27c7c4aefe | |
| ToppCell | normal_Lung-Endothelial_cells-Tumor_ECs|normal_Lung / Location, Cell class and cell subclass | 3.67e-04 | 184 | 34 | 3 | 7ee98acda030366ac6cf3890a6d93fd0426712ed | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.67e-04 | 184 | 34 | 3 | a12a6a481e78adc62da1904431f62b119f70b15f | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.67e-04 | 184 | 34 | 3 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.73e-04 | 185 | 34 | 3 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-04 | 186 | 34 | 3 | d65fa6d8e8a195ea10cfde1499d096d6acf7a634 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.79e-04 | 186 | 34 | 3 | 4e983de6d2515082f9e555f4f949cec84281c140 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.79e-04 | 186 | 34 | 3 | ffbc78058be8f0dc2e0335cc4c3195a636d17721 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.79e-04 | 186 | 34 | 3 | ed924852cd7132c8f6703522037dc22bd2c83193 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-04 | 186 | 34 | 3 | 1e67bfb248366d7395efdd2d5e70a97bdb2e68af | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.85e-04 | 187 | 34 | 3 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.85e-04 | 187 | 34 | 3 | 83930ef55191eff9006113feaeabb3c2fa21fd05 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.85e-04 | 187 | 34 | 3 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.85e-04 | 187 | 34 | 3 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-04 | 187 | 34 | 3 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.85e-04 | 187 | 34 | 3 | 12129e02638c20d9b7c1c6e512d48bfd966e1029 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells-Tumor_ECs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.85e-04 | 187 | 34 | 3 | be5f8c5802b0fa8cc1e274fdf06b13eb8ceb8ad4 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 3.85e-04 | 187 | 34 | 3 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.91e-04 | 188 | 34 | 3 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-B_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.91e-04 | 188 | 34 | 3 | 7b56c680e9f1851cb961b0f8faeeb987685ae36d | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-04 | 188 | 34 | 3 | 405efea75233ecf70f7d19b630230798d817b7f2 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.91e-04 | 188 | 34 | 3 | a11b12f1857953bcdbfb5f25e127f2350c39567d | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.91e-04 | 188 | 34 | 3 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | moderate-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.97e-04 | 189 | 34 | 3 | 6011b747e27d61d222380a7bffdd921a68e9b657 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 3.97e-04 | 189 | 34 | 3 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.97e-04 | 189 | 34 | 3 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.03e-04 | 190 | 34 | 3 | 40d8b3403f4e38436b961cd3a2e69826cbae3042 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.03e-04 | 190 | 34 | 3 | f6cbf6d292f488ada5f7581e1dceba6198b933d1 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.03e-04 | 190 | 34 | 3 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 4.03e-04 | 190 | 34 | 3 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.03e-04 | 190 | 34 | 3 | 3cf464664d6aa22b212e60b70885953887e92483 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.03e-04 | 190 | 34 | 3 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.03e-04 | 190 | 34 | 3 | a9a705455019e28d655636de73b07540798f82e6 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.09e-04 | 191 | 34 | 3 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.09e-04 | 191 | 34 | 3 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.09e-04 | 191 | 34 | 3 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | CV-Severe-5|Severe / Virus stimulation, Condition and Cluster | 4.09e-04 | 191 | 34 | 3 | d04f93fc85c882260ca4d5b4768504fbf8a47984 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 4.15e-04 | 192 | 34 | 3 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.15e-04 | 192 | 34 | 3 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.15e-04 | 192 | 34 | 3 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-SVEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.15e-04 | 192 | 34 | 3 | c3dda7c48732b0b8bde36de282d64192f5e9b98f | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-04 | 193 | 34 | 3 | 54024a373e42e1c0bcc327dc084564b83b63a9d4 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 4.22e-04 | 193 | 34 | 3 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-04 | 193 | 34 | 3 | 81d908594d2983ba7e7c1ec25afdde4315d9690e | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.22e-04 | 193 | 34 | 3 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 5.75e-05 | 195 | 32 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | Proteinuria | 1.19e-04 | 15 | 32 | 2 | HP_0000093 | |
| Disease | epilepsy (implicated_via_orthology) | 7.30e-04 | 163 | 32 | 3 | DOID:1826 (implicated_via_orthology) | |
| Disease | reticulocyte count | 8.00e-04 | 1045 | 32 | 6 | EFO_0007986 | |
| Disease | retinal drusen | 1.41e-03 | 51 | 32 | 2 | EFO_1001155 | |
| Disease | generalised epilepsy | 1.46e-03 | 52 | 32 | 2 | EFO_0005917 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 1.60e-03 | 801 | 32 | 5 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | pyroglutamine measurement | 1.81e-03 | 58 | 32 | 2 | EFO_0005408 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QAMTHFACLSSKYMC | 876 | Q9UPW8 | |
| SLHVASCYVCGGMNM | 286 | Q14264 | |
| SECTQMDHLGCMHYT | 126 | Q9H2A2 | |
| SMSNCHSSLMAGCLG | 156 | Q8IYX3 | |
| TCAALLMSPYCGMHS | 3361 | Q9NR09 | |
| YCMAVCGSAMSQSLL | 336 | P05067 | |
| SNGGIMCNICHKMYS | 1031 | Q6ZN30 | |
| MCNICHKMYSNKGTL | 1036 | Q6ZN30 | |
| SVSGMTMCYACNKSI | 46 | Q92974 | |
| CKGSSYMISVNMHCS | 106 | P49685 | |
| TMTCMKGTYLVHLTC | 496 | P24386 | |
| SVCHGSKMSMFRNCF | 251 | A8MXD5 | |
| YAGCTKTVLMNHCSG | 5086 | Q02817 | |
| CNSCGHQMLKYVSTS | 576 | Q13370 | |
| CSATCTTGVMSAYAM | 576 | Q86TH1 | |
| YSSCNDAMEMTKCLS | 456 | Q8NG31 | |
| SMLCKALSTCASHFM | 231 | P58182 | |
| SCSYCTMAKKLFHDM | 76 | Q9NS18 | |
| CKMSYSKACHLRTHM | 971 | A0A0U1RQI7 | |
| CTHEQMMCSKTCYNS | 351 | O43405 | |
| MMCSKTCYNSVNIAF | 356 | O43405 | |
| CELTDSMQCPGTYMH | 26 | Q8TDM5 | |
| KRSNCYMVCAGESMS | 1481 | Q92736 | |
| THMPRNCYHSATLCM | 66 | Q9UQF0 | |
| KRHMASYSMCSDPST | 291 | Q5T2D2 | |
| MCDGSHLASTLRYCM | 6 | Q8N0U2 | |
| SYQSHDCSGACLMKM | 141 | Q96T68 | |
| AMTHFSCLSSKYMCP | 1421 | Q8NB66 | |
| HTMCYCEDGFMHCTM | 726 | P04275 | |
| TEMHCMSGHSNFVSC | 56 | Q9Y263 | |
| MVCGSDGHSYTSKCK | 146 | Q08629 | |
| SHCCSRYLCMGAMSL | 251 | O43609 | |
| AMTHFACLSSKYMCP | 801 | O14795 | |
| IHTNSMCFTMKTSCV | 36 | Q9Y5X0 | |
| THYSCGECMKHSSTK | 201 | Q8TF45 | |
| YCGKMCRSSNSMAFL | 1541 | Q9C0G0 |